James Vollins
Compliance Officer chez EIGER BIOPHARMACEUTICALS, INC.
Fortune : - $ au 30/04/2024
Profil
James A.
Vollins is currently the Secretary & Chief Compliance Officer at Eiger BioPharmaceuticals, Inc. Prior to this, he held the same position at BioDelivery Sciences International, Inc. from 2018 to 2022 and at Bio Products Laboratory Ltd.
from 2014 to 2018.
Vollins received his undergraduate degree from Wesleyan University and his graduate degree from Case Western Reserve University School of Law.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 30/04/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de James Vollins
| Sociétés | Poste | Début |
|---|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Compliance Officer | 13/04/2023 |
Anciens postes connus de James Vollins
| Sociétés | Poste | Fin |
|---|---|---|
| BIODELIVERY SCIENCES INTERNATIONAL, INC. | Compliance Officer | 22/03/2022 |
Bio Products Laboratory Ltd.
 Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Compliance Officer | 01/10/2018 |
Formation de James Vollins
| Case Western Reserve University School of Law | Graduate Degree |
| Wesleyan University | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| EIGER BIOPHARMACEUTICALS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
BioDelivery Sciences International, Inc.
 BioDelivery Sciences International, Inc. Pharmaceuticals: MajorHealth Technology BioDelivery Sciences International, Inc. operates as a pharmaceutical company engaged in the development and commercialization of new applications of approved therapeutics to address important unmet medical needs. Its products include Symproic and Belbuca. The company was founded on January 6, 1997 and is headquartered in Raleigh, NC. | Health Technology |
Bio Products Laboratory Ltd.
Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Health Technology |
